Several studies confirmed that LRIG2 exerted the value of prognosis in diverse types of human cancers, including non-small cell lung cancer [34], uterine cervical cancer [35], and hepatocellular carcinoma [36]. This evidence concerns the gene LRIG2 and non-small cell lung carcinoma.